Group GTS. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med. 1985;312(23):1465–72.

Article  Google Scholar 

Sauer R, Fietkau R, Wittekind C, Rödel C, Martus P, Hohenberger W, et al. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. Colorectal Dis. 2003;5(5):406–15.

Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo LJ, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010;11(9):835–44.

Article  PubMed  Google Scholar 

Habr-Gama A, de Souza PM, Ribeiro U, Nadalin W, Gansl R, Sousa AH, et al. Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum. 1998;41(9):1087–96.

Article  CAS  PubMed  Google Scholar 

Habr-Gama A, Perez R, Proscurshim I, Gama-Rodrigues J. Complete clinical response after neoadjuvant chemoradiation for distal rectal cancer. Surg Oncol Clin N Am. 2010;19(4):829–45.

Article  PubMed  Google Scholar 

Dattani M, Heald RJ, Goussous G, Broadhurst J, São Julião GP, Habr-Gama A, et al. Oncological and survival outcomes in watch and wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and pooled analysis. Ann Surg. 2018;268(6):955–67.

Article  PubMed  Google Scholar 

Nahas SC, RizkallahNahas CS, Sparapan Marques CF, Ribeiro U, Cotti GC, Imperiale AR, et al. Pathologic complete response in rectal cancer: can we detect it? Lessons learned from a proposed randomized trial of watch-and-wait treatment of rectal cancer. Dis Colon Rectum. 2016;59(4):255–63.

Article  PubMed  Google Scholar 

Ryan JE, Warrier SK, Lynch AC, Ramsay RG, Phillips WA, Heriot AG. Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review. Colorectal Dis. 2016;18(3):234–46.

Article  CAS  PubMed  Google Scholar 

Alwers E, Jansen L, Kather J, Amitay E, Bläker H, Kloor M, et al. Response to neoadjuvant treatment among rectal cancer patients in a population-based cohort. Int J Colorectal Dis. 2021;36(1):177–85.

Article  PubMed  Google Scholar 

Huang Y, Lee D, Young C. Predictors for complete pathological response for stage II and III rectal cancer following neoadjuvant therapy - a systematic review and meta-analysis. Am J Surg. 2020;220(2):300–8.

Article  PubMed  Google Scholar 

Nahas SC, Nahas CSR, Cama GM, de Azambuja RL, Horvat N, Marques CFS, et al. Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer. Abdom Radiol (NY). 2019;44(11):3632–40.

Article  PubMed  Google Scholar 

Safatle-Ribeiro AV, Marques CFS, Pires C, Arraes L, Baba ER, Meirelles L, et al. Diagnosis of clinical complete response by probe-based confocal laser endomicroscopy (pCLE) after chemoradiation for advanced rectal cancer. J Gastrointest Surg. 2021;25(2):357–68.

Article  PubMed  Google Scholar 

Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–45.

Article  CAS  PubMed  Google Scholar 

Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Witz IP. Yin-yang activities and vicious cycles in the tumor microenvironment. Cancer Res. 2008;68(1):9–13.

Article  CAS  PubMed  Google Scholar 

Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more. Nat Rev Cancer. 2016;16(7):431–46.

Article  CAS  PubMed  Google Scholar 

Mittrücker HW, Visekruna A, Huber M. Heterogeneity in the differentiation and function of CD8⁺ T cells. Arch Immunol Ther Exp (Warsz). 2014;62(6):449–58.

Article  PubMed  Google Scholar 

Kakar S, Shi C, Berho ME, Driman DK, Fitzgibbons P, Frankel WL, et al. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum [Internet]. Version ColonRectum 4.0.0.0; posted June 2017. Northfield (IL): College of American Pathologists. 2017. Available from: https://www.cap.org/cancerprotocols.

Ryan R, Gibbons D, Hyland JM, Treanor D, White A, Mulcahy HE, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005;47(2):141–6.

Article  CAS  PubMed  Google Scholar 

Hosmer D, Lemeshow S. Applied logistic regression, Chapter 5. 2nd ed. New York: Wiley; 2000, pp 160 – 4. https://doi.org/10.1002/0471722146.

Giglia MD, Stein SL. Overlooked long-term complications of colorectal surgery. Clin Colon Rectal Surg. 2019;32(3):204–11.

Article  PubMed  PubMed Central  Google Scholar 

Krauthamer M, Rouvinov K, Ariad S, Man S, Walfish S, Pinsk I, et al. A study of inflammation-based predictors of tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Oncology. 2013;85(1):27–32.

Article  CAS  PubMed  Google Scholar 

Dudani S, Marginean H, Tang PA, Monzon JG, Raissouni S, Asmis TR, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation. BMC Cancer. 2019;19(1):664.

Article  PubMed  PubMed Central  Google Scholar 

Kim TG, Park W, Kim H, Choi DH, Park HC, Kim SH, et al. Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy. Tumori. 2019;105(5):434–40.

Article  CAS  PubMed  Google Scholar 

Braun LH, Baumann D, Zwirner K, Eipper E, Hauth F, Peter A, et al. Neutrophil-to-lymphocyte ratio in rectal cancer-novel biomarker of tumor immunogenicity during radiotherapy or confounding variable? Int J Mol Sci. 2019;20(10). https://doi.org/10.3390/ijms20102448

Jeon BH, Shin US, Moon SM, Choi JI, Kim MS, Kim KH, et al. Neutrophil to lymphocyte ratio: a predictive marker for treatment outcomes in patients with rectal cancer who underwent neoadjuvant chemoradiation followed by surgery. Ann Coloproctol. 2019;35(2):100–6.

Article  PubMed  PubMed Central  Google Scholar 

Ward WH, Goel N, Ruth KJ, Esposito AC, Lambreton F, Sigurdson ER, et al. Predictive value of leukocyte- and platelet-derived ratios in rectal adenocarcinoma. J Surg Res. 2018;232:275–82.

Article  PubMed  Google Scholar 

Zhang Y, Liu X, Xu M, Chen K, Li S, Guan G. Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy. Sci Rep. 2020;10(1):8017.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Azab B, Camacho-Rivera M, Taioli E. Average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects. PLoS ONE. 2014;9(11):e112361.

Article  PubMed  PubMed Central  Google Scholar 

Huguet E, Maccallini G, Pardini P, Hidalgo M, Obregon S, Botto F, et al. Reference values for neutrophil to lymphocyte ratio (NLR), a biomarker of cardiovascular risk, according to age and sex in a latin american population. Curr Probl Cardiol. 2021;46(3):100422.

Article  PubMed  Google Scholar 

Wang J, Zhang F, Jiang F, Hu L, Chen J, Wang Y. Distribution and reference interval establishment of neutral-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in Chinese healthy adults. J Clin Lab Anal. 2021;35(9):e23935.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamid HKS, Davis GN, Trejo-Avila M, Igwe PO, Garcia-Marín A. Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: A systematic review and meta-analysis. Surg Oncol. 2021;37:101556.

Article  PubMed  Google Scholar 

Li X, Dai D, Chen B, Tang H, Xie X, Wei W. The value of neutrophil-to-lymphocyte ratio for response and prognostic effect of neoadjuvant chemotherapy in solid tumors: A systematic review and meta-analysis. J Cancer. 2018;9(5):861–71.

Article  PubMed  PubMed Central  Google Scholar 

Petrie HT, Klassen LW, Kay HD. Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol. 1985;134(1):230–4.

Article  CAS  PubMed  Google Scholar 

Mantovani A, Marchesi F, Male